Showing results (41-50 of 71) with videos related to
Sort By:
Pageof 8
Cancer Epidemiology|June 19, 2013
Diabetes, metformin use, and colorectal cancer survival in postmenopausal womenFurha Iram Cossor, Lucile L Adams-Campbell, Rowan T Chlebowski, et al.Obesity (Silver Spring, Md.)|March 19, 2016
Body shape, adiposity index, and mortality in postmenopausal women: Findings from the Women's Health InitiativeCynthia A Thomson, David O Garcia, Betsy C Wertheim, et al.Cancer|June 13, 2020
Insulin resistance and breast cancer incidence and mortality in postmenopausal women in the Women's Health InitiativeKathy Pan, Rowan T Chlebowski, Joanne E Mortimer, et al.Cancer Epidemiology|April 22, 2016
A prospective study of soluble receptor for advanced glycation end-products and colorectal cancer risk in postmenopausal womenLiang Chen, Zhigang Duan, Lesley Tinker, et al.International Journal of Cancer|January 27, 2019
Circulating androgens and postmenopausal ovarian cancer risk in the Women's Health Initiative Observational StudyBritton Trabert, Kara A Michels, Garnet L Anderson, et al.The Journal of Clinical Endocrinology and Metabolism|November 8, 2016
Insulinlike Growth Factor Binding Protein-1 and Ghrelin Predict Health Outcomes Among Older Adults: Cardiovascular Health Study CohortRobert C Kaplan, Garrett Strizich, Chino Aneke-Nash, et al.International Journal of Cancer|February 4, 2015
Red blood cell folate and plasma folate are not associated with risk of incident colorectal cancer in the Women's Health Initiative observational studyMarian L Neuhouser, Ting-Yuan David Cheng, Shirley A A Beresford, et al.The Lancet. Oncology|March 10, 2012
Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trialGarnet L Anderson, Rowan T Chlebowski, Aaron K Aragaki, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2012
Diabetes, metformin, and breast cancer in postmenopausal womenRowan T Chlebowski, Anne McTiernan, Jean Wactawski-Wende, et al.NPJ Breast Cancer|November 16, 2017
A metastasis biomarker (MetaSite Breast™ Score) is associated with distant recurrence in hormone receptor-positive, HER2-negative early-stage breast cancerJoseph A Sparano, Robert Gray, Maja H Oktay, et al.Pageof 8